85196-33-4

Basic information

• Product Name: Acetic acid, (2,4-dinitrophenoxy)-, ethyl ester
• Synonyms: (2,4-Dinitro-phenoxy)-acetic acid ethyl ester;2,4-Dinitro-phenoxy-essigsaeure-ethylester;(2,4-Dinitro-phenoxy)-essigsaeure-aethylester
• CAS NO: 85196-33-4
• Molecular Formula: C10H10N2O7
• Molecular Weight: 270.199
• Mol File: 85196-33-4.mol
• Article Data: 2

Chemical Properties

• Melting Point: 76.5 - 78 °C (ethanol)
• CAS DataBase Reference: Acetic acid, (2,4-dinitrophenoxy)-, ethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Acetic acid, (2,4-dinitrophenoxy)-, ethyl ester(85196-33-4)
• EPA Substance Registry System: Acetic acid, (2,4-dinitrophenoxy)-, ethyl ester(85196-33-4)

Safety Data

• Hazardous Substances Data: 85196-33-4(Hazardous Substances Data)

Upstream product

• 64-17-5 ethanol 
• 25141-25-7 2,4-dinitrophenoxyacetic acid 
• 2555-49-9 phenoxyacetic acid ethyl ester 
• 122-59-8 2-phenoxyacetic acid 
• 584-48-5 2,4-dinitrobromobenzene 
• 623-50-7 ethyl 2-hydroxyacetate 

Downstream Products

• 89976-75-0 6-amino-2H-1,4-benzoxazin-3(4H)-one 
• 72757-46-1 (2,4-dinitro-phenoxy)-acetic acid amide 

Relevant articles and documents

EGFR-targeting fluorescence quenching probe and preparation method and application thereof

The invention relates to the technical field of molecular probes, and discloses an EGFR-targeting fluorescence quenching probe and a preparation method and application thereof. The fluorescence quenching probe structurally comprises a pharmacodynamic skeleton structure, a fluorescence quenching group and a fluorescence labeling group, wherein the fluorescence labeling group is selected from BODIPYFL dye; and the fluorescence quenching group is selected from 2, 4-dinitrophenol. The pharmacodynamic skeleton structure can be combined with EGFR protein in a targeting mode, and when the quenchinggroup in the molecular probe leaves, the fluorescence labeling group can conduct specific tracing and imaging; and by means of molecular imaging, the expression process of specific cells and moleculescan be observed in real time, a target spot is traced, and therefore disease development status evaluation and accurate detection of EGFR mutation typing of lung cancer patients are achieved at the molecular pathological level.